Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

BACKGROUND: Live respiratory syncytial virus (RSV) candidate vaccine LIDΔM2-2 is attenuated by deletion of the RSV RNA regulatory protein M2-2, resulting in upregulated viral gene transcription and antigen expression but reduced RNA replication. METHODS: RSV-seronegative children ages 6–24 months re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: McFarland, Elizabeth J, Karron, Ruth A, Muresan, Petronella, Cunningham, Coleen K, Valentine, Megan E, Perlowski, Charlotte, Thumar, Bhagvanji, Gnanashanmugam, Devasena, Siberry, George K, Schappell, Elizabeth, Barr, Emily, Rexroad, Vivian, Yogev, Ram, Spector, Stephen A, Aziz, Mariam, Patel, Nehali, Cielo, Mikhaela, Luongo, Cindy, Collins, Peter L, Buchholz, Ursula J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5894092/
https://ncbi.nlm.nih.gov/pubmed/29509911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy040
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi